275 research outputs found

    Strategies to increase the resectability of hepatocellular carcinoma

    Get PDF
    © 2015 Baishideng Publishing Group Inc. Hepatocellular carcinoma (HCC) is best treated by liver transplantation, but the applicability of transplantation is greatly limited. Tumor resection in partial hepatectomy is hence resorted to. However, in most parts of the world, only 20%-30% of HCCs are resectable. The main reason for such a low resectability is a future liver remnant too small to be sufficient for the patient. To allow more HCC patients to undergo curative hepatectomy, a variety of ways have been developed to increase the resectability of HCC, mainly ways to increase the future liver remnants in patients through hypertrophy. They include portal vein embolization, sequential transarterial chemoembolization and portal vein embolization, staged hepatectomy, two-staged hepatectomy with portal vein ligation, and Associating Liver Partition and Portal Vein Ligation in Staged Hepatectomy. Herein we review, describe and evaluate these different ways, ways that can be life-saving.published_or_final_versio

    Advanced in Hepatic Surgery

    Get PDF

    Importance of surgical margin in the outcomes of hepatocholangiocarcinoma

    Get PDF
    published_or_final_versio

    An extra-adrenal pheochromocytoma mimicking a primary liver cancer

    Get PDF
    published_or_final_versio

    Variation of stemness markers expression in tumor nodules from synchronous multi-focal hepatocellular carcinoma - an immunohistochemical study

    Get PDF
    published_or_final_versio

    Management of hepatocellular carcinoma with portal vein tumor thrombosis: Review and update at 2016

    Get PDF
    published_or_final_versio

    Media coverage of liver transplant events promotes donations from the deceased

    Get PDF
    Commentarypublished_or_final_versio
    • …
    corecore